Lars Fruergaard Jorgensen
Chief Executive Officer presso NOVO NORDISK A/S
Profilo
Lars Fruergaard Jrgensen è vicepresidente della European Federation of Pharmaceutical Industries & Assns, vicepresidente del consiglio di sorveglianza di Carlsberg A/S, membro del consiglio di sorveglianza di Carlsberg Breweries A/S, presidente e amministratore delegato di Novo Nordisk Ltd., presidente e amministratore delegato di Novo Nordisk A/S e presidente di Harno Invest A/S. Fa parte del consiglio di amministrazione di Carlsberg A/S e Carlsberg Breweries A/S. Il signor Jrgensen è stato precedentemente impiegato come membro del consiglio di sorveglianza di Innate Pharma SA, come vicepresidente del settore finanziario e informatico di Novo Nordisk Pharmaceutical SAS e come presidente di NNE Pharmaplan A/S. È stato anche membro del consiglio di amministrazione di ZymoGenetics, Inc. e NNIT A/S. Si è laureato all'Università di Aarhus.
Posizioni attive di Lars Fruergaard Jorgensen
Società | Posizione | Inizio |
---|---|---|
NOVO NORDISK A/S | Chief Executive Officer | 01/01/2017 |
Harno Invest A/S
Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark | Chairman | 25/01/2011 |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Chief Executive Officer | 01/09/2004 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Corporate Officer/Principal | 01/01/2021 |
Precedenti posizioni note di Lars Fruergaard Jorgensen
Società | Posizione | Fine |
---|---|---|
NNIT A/S | Director/Board Member | 06/03/2015 |
INNATE PHARMA | Director/Board Member | 04/03/2013 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Director/Board Member | 08/10/2010 |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Director of Finance/CFO | 01/01/2004 |
Carlsberg Breweries A/S
Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Formazione di Lars Fruergaard Jorgensen
University of Aarhus | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
NOVO NORDISK A/S | Health Technology |
CARLSBERG A/S | Consumer Non-Durables |
INNATE PHARMA | Health Technology |
NNIT A/S | Technology Services |
Aziende private | 7 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Carlsberg Breweries A/S
Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Consumer Non-Durables |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Health Technology |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Health Services |
Harno Invest A/S
Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark | Finance |
NNE Pharmaplan A/S
NNE Pharmaplan A/S Pharmaceuticals: MajorHealth Technology NNE Pharmaplan A/S produces pharmaceutical products. The company is based in Soborg, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Lars Fruergaard Jorgensen